Skip to main content

Global Mobile Cardiac Telemetry Market to Witness Rapid Growth Driven by Rising Prevalence of Cardiovascular Diseases

SkyQuest projects that the mobile cardiac telemetry market will attain a value of USD 2300 million by 2030, with a CAGR of 12.1% over the forecast period (2023-2030). Mobile cardiac telemetry (MCT) devices are gaining popularity as they offer the numerous benefits over traditional cardiac monitoring methods. These devices are non-invasive, they do not require surgery or invasive procedures, making them a comfortable option for patients. They are also portable, which allows patients to continue their daily activities while being monitored.

Westford,USA, June 21, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, mobile cardiac telemetry  market is being driven by the increasing prevalence of cardiovascular diseases worldwide. Therefore, the ability of these systems to diagnose heart rhythm disorders and detect auto-triggered cardiac events is a significant factor in their growth. In addition, the increasing penetration of the internet along with the rising demand for wearable products such as the smartwatches and fitness bands are further boosting the market.

Browse in-depth TOC on “Mobile Cardiac Telemetry Market”

  • Pages – 260
  • Tables – 60
  • Figures – 75

Medicomp, Inc. collaborated with Lenox Hill Hospital to monitor the electrical conduction of the heart of COVID-19 patients who were receiving specific medications using its TelePatch- mobile cardiac telemetry (MCT) device in 2022. This partnership highlights the potential of MCT devices to monitor patients in real-time, especially during a pandemic when remote monitoring is essential.

Prominent Players in Mobile Cardiac Telemetry Market

  • BioTelemetry, Inc.
  • Preventice Solutions
  • iRhythm Technologies Inc.
  • Medicomp Inc.
  • Biotricity Inc.
  • Applied Cardiac Systems Inc.
  • Hill-Rom Holdings Inc.
  • Philips Healthcare
  • Medtronic PLC
  • Zoll Medical Corporation
  • Cardionet Inc.
  • GE Healthcare
  • Welch Allyn Inc.
  • BioTel Heart
  • Infosys Limited
  • Comarch SA
  • Infinium Medical
  • Digi International Inc.
  • Telerhythmics LLC
  • Medic4all Group.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/mobile-cardiac-telemetry-market

Patch-Based Segment is Expected to Grow the Market Due toRising Cases of Arrhythmias

The mobile cardiac telemetry market is expected to witness profitable growth in the patch-based segment during the forecast period. Patch-based continuous cardiac rhythm monitoring (CCRM) has become a valuable clinical tool for measuring and monitoring bradyarrhythmia and tachyarrhythmia in the outpatient setting. These patch-based CRM devices have been studied as an alternative to traditional Holter monitoring and have proven to be effective and convenient solutions for detecting clinically significant arrhythmias, driving demand in the market.

The market in North America isexpected to dominate the market owing to the region’s high prevalence of cardiovascular disease. According to the American Heart Association, one person dies from cardiovascular disease every 36 seconds in U.S. Every year, approximately 659,000 people die from heart disease, accounting for one in every four deaths in the country.

Hospital Segment is Expected to Dominatethe Market Due to rise in Minimally Invasive Procedures

The hospitalsector emerged as the dominant market segment, accounting for more than 60% of the total revenue. The sector’s growth can be attributed to the rise in minimally invasive procedures performed in hospitals. The cardiac centre category is projected to witness the fastest growth during the forecast period, owing to an increase in cardiac centres and easy access to surgeons working in these facilities.

Regional markets in Asia Pacificare expected to experience the rapid growth. The growing prevalence of obesity is expected to drive the market. According to the Statista Research Department, Asia Pacific has the world’s highest proportion of overweight and obese people. Furthermore, the Asia Pacific regions are expected to experience rapid growth during the forecast period of 2023-2030, owing to the rising adoption of sedentary lifestyle by the population which leads to physical inactivity, a high death rate due to cardiovascular diseases and unhealthy dietary habits in the region.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/mobile-cardiac-telemetry-market

A comprehensive analysis of the major players in the mobile cardiac telemetrymarket has been recently conducted in a report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavours to develop innovative solutions to cater to the growing demand.

Key Developments in Mobile Cardiac Telemetry Market

  • ZOLL Medical, a major player in the resuscitation and data solutions acquired Core Health Technologies, Inc. in 2020. This strategic move expanded ZOLL’s product offerings and helped it become a leading provider of cloud-based device connectivity services. As a result, ZOLL has strengthened its position in the mobile cardiac telemetry market and the acquisition has introduced greater competition.
  • VitalConnect, a leader in remote patient monitoring, introduced VitalPatch RTM, a mobile cardiac telemetry solution in 2022. This platform offers a programmable and adaptable approach to meet cardiac monitoring needs for various healthcare settings. VitalPatch RTM is a wireless, disposable patch that continuously monitors electrocardiogram (ECG), heart rate, and respiratory rate.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/mobile-cardiac-telemetry-market

Key Questions Answered in Mobile Cardiac Telemetry Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global In-vitro Fertilization Microscopes Market

Global Dental Burs Market

Global Medical Alert Systems Market

Global Medical Pendant Market

Global Intracranial Pressure Monitoring Devices Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.